Safety and efficacy of ciprofol vs. propofol for sedation in intensive care unit patients with mecha...
Safety and efficacy of ciprofol vs. propofol for sedation in intensive care unit patients with mechanical ventilation: a multi-center, open label, randomized, phase 2 trial
About this item
Full title
Author / Creator
Liu, Yongjun , Yu, Xiangyou , Zhu, Duming , Zeng, Jun , Lin, Qinhan , Zang, Bin , Chen, Chuanxi , Liu, Ning , Liu, Xiao , Gao, Wei and Guan, Xiangdong
Publisher
China: Lippincott Williams & Wilkins
Journal title
Language
English
Formats
Publication information
Publisher
China: Lippincott Williams & Wilkins
Subjects
More information
Scope and Contents
Contents
Ciprofol (HSK3486; Haisco Pharmaceutical Group Co., Ltd., Chengdu, China), developed as a novel 2,6-disubstituted phenol derivative showed similar tolerability and efficacy characteristics as propofol when applicated as continuous intravenous infusion for 12 h maintenance sedation in a previous phase 1 trial. The phase 2 trial was designed to inves...
Alternative Titles
Full title
Safety and efficacy of ciprofol vs. propofol for sedation in intensive care unit patients with mechanical ventilation: a multi-center, open label, randomized, phase 2 trial
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_6ba5f11bde4b424c8d7f21b4824d1ce8
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6ba5f11bde4b424c8d7f21b4824d1ce8
Other Identifiers
ISSN
0366-6999
E-ISSN
2542-5641
DOI
10.1097/CM9.0000000000001912
